From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein
- PMID: 27485738
- PMCID: PMC5095496
- DOI: 10.1111/imm.12656
From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein
Abstract
Zika virus (ZikV) has emerged as a potential threat to human health worldwide. A member of the Flaviviridae, ZikV is transmitted to humans by mosquitoes. It is related to other pathogenic vector-borne flaviviruses including dengue, West Nile and Japanese encephalitis viruses, but produces a comparatively mild disease in humans. As a result of its epidemic outbreak and the lack of potential medication, there is a need for improved vaccine/drugs. Computational techniques will provide further information about this virus. Comparative analysis of ZikV genomes should lead to the identification of the core characteristics that define a virus family, as well as its unique properties, while phylogenetic analysis will show the evolutionary relationships and provide clues about the protein's ancestry. Envelope glycoprotein of ZikV was obtained from a protein database and the most immunogenic epitope for T cells and B cells involved in cell-mediated immunity, whereas B cells are primarily responsible for humoral immunity. We mainly focused on MHC class I potential peptides. YRIMLSVHG, VLIFLSTAV and MMLELDPPF, GLDFSDLYY are the most potent peptides predicted as epitopes for CD4+ and CD8+ T cells, respectively, whereas MMLELDPPF and GLDFSDLYY had the highest pMHC-I immunogenicity score and these are further tested for interaction against the HLA molecules, using in silico docking techniques to verify the binding cleft epitope. However, this is an introductory approach to design an epitope-based peptide vaccine against ZikV; we hope that this model will be helpful in designing and predicting novel vaccine candidates.
Keywords: Immune Epitope Database; MHC class; Zika virus; artificial neural network; epitopes; immunogenomics.
© 2016 John Wiley & Sons Ltd.
Figures
References
-
- WHO , Zika situation report. URL http://www.who.int/emergencies/zika-virus/situation-report/10-march-2016... 2016.
-
- Samarasekera U, Triunfol M. Concern over Zika virus grips the world. Lancet 2016; 387:521–4. - PubMed
-
- Kuno G, Chang G‐JJ. Full‐length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol 2007; 152:687–96. - PubMed
-
- Fields BN, Knipe DM, Howley PM. Fields' virology, 5th edn Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007:2
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
